Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07362082 · ClinicalTrials.gov registry record · NA
A Clinical Trial of Telehealth Treatment for Opioid Use Disorders
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 470
- Enrollment target
NCT07362082: Clinical Trial NA study, sponsored by Yale University.
NCT07362082 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 470 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07362082, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 470 participants
- Enrollment target
Study Summary
This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
Primary Outcome
Overall attendance will be measured by attendance (yes or no) at the first MOUD appointment within 30 days of enrollment.
Interventions
- DEVICE RecoveryPad platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What is known before NCT07362082 opens enrollment
NCT07362082 is an interventional study that assigns participants to a tested intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which RecoveryPad platform is the first listed.
NCT07362082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07362082 about?
NCT07362082 is a clinical study titled "A Clinical Trial of Telehealth Treatment for Opioid Use Disorders". This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
What is the current status of trial NCT07362082?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 470 participants. The study started on 2026-06-01. Estimated completion is 2027-12-01.
What interventions are being tested in trial NCT07362082?
The interventions under investigation include: RecoveryPad platform (DEVICE).
Who is sponsoring clinical trial NCT07362082?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07362082's enrollment target sits among peer trials
470 221st of 2000 higher than 1,779 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05256940 · 470 participants · NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
- NCT05458219 · 470 participants · Phase 1
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- NCT05850689 · 470 participants · Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- NCT05935384 · 470 participants
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI